Find Adverse Event Cases
   _help
Fuzzy Search?
DRUG NAME

 
MANUFACTURER NAME

 
DRUG INDICATION

 
EVENT DESCRIPTION

 
OUTCOME CODE


DRUG'S ROLE CODE


PATIENT GENDER


REPORTER'S OCCUPATION
PATIENT MASS - kg
Lo TO Hi

PATIENT AGE - years
Lo TO Hi
Calendar REPORT DATE
TO

Calendar MANUFACTURER RECEIPT DATE
TO

Calendar FDA RECEIPT DATE
TO
Cases 211 to 240 of 3338     Drug Names: clozapine AND the outcome of the event was DE
« Previous 1 2 ... 4 5 6 7 8 9 10 11 12 ... 111 112 Next »
Case # YYQQ ISR Reactions Outcomes Primary Suspect(s) Event Date Manufacturer Age y Mass kg Sex  
3397064 ▸99Q43411631WHITE BLOOD CELL COUNT INCREAS...DECLOZAPINEZENITH GOLDLINE...80.0 MLink    xml
3399540 ▸99Q43422834DEHYDRATION,SEPSIS NOSDE,HOCLOZAPINEZENITH GOLDLINE...83.0 MLink    xml
3399546 ▸99Q43422824SEPSIS NOS,URINARY TRACT...DECLOZAPINEZENITH GOLDLINE...84.0 FLink    xml
3399555 ▸99Q43422819PNEUMONIA NOSDECLOZAPINEZENITH GOLDLINE...86.0 FLink    xml
3399560 ▸99Q43422832PNEUMONIA NOSDECLOZAPINEZENITH GOLDLINE...87.0 FLink    xml
3399569 ▸99Q43422843PULMONARY EMBOLISMDECLOZAPINEZENITH GOLDLINE...48.0 MLink    xml
  ▸00Q23484971PULMONARY EMBOLISMDECLOZAPINEZENITH GOLDLINE...48.0 M 
3399619 ▸99Q43422883ARRHYTHMIA NOSDECLOZAPINEZENITH GOLDLINE...58.0 MLink    xml
  ▸00Q13458697ARRHYTHMIA NOS,DRUG INTERACTIO...DECLOZAPINEZENITH GOLDLINE...58.0 M 
3399742 ▸99Q43422835CARDIAC FAILURE NOSDECLOZAPINEZENITH GOLDLINE...40.0 MLink    xml
  ▸00Q23484970CARDIAC FAILURE NOSDECLOZAPINEZENITH GOLDLINE...40.0 M 
3399933 ▸99Q43422888CARDIAC FAILURE NOSDECLOZAPINEZENITH GOLDLINE...71.0 FLink    xml
  ▸00Q23484976PULMONARY EMBOLISMDECLOZAPINEZENITH GOLDLINE...71.0 F 
3401111 ▸99Q43415503CEREBROVASCULAR ACCIDENT NOSDECLOZAPINEZENITH GOLDLINE...70.0 MLink    xml
3403801 ▸99Q43421061MYOCARDIAL INFARCTION,NEUTROPE...DE,OTCLOZAPINE11/26/99NOVARTIS PHARMA...70.0 MLink    xml
  ▸99Q43432067LEUCOPENIA NOS,MYOCARDIAL...DE,OTLEPONEX (CLOZA...11/26/99NOVARTIS PHARMA...70.0 M 
3406868 ▸99Q43425995DRUG EFFECT INCREASED,DRUG...DEEFFEXOR07/26/99WYETH LABS (RA)47.0 FLink    xml
3407223 ▸99Q43423594ACUTE CIRCULATORY FAILURE,LEFT...DELEPONEX (CLOZA...12/05/99NOVARTIS PHARMA...46.0 MLink    xml
  ▸00Q23483734ACUTE CIRCULATORY FAILURE,LEFT...DECLOZAPINE12/05/99NOVARTIS PHARMA...46.0 M 
3407930 ▸99Q43422677DYSPNOEA NOS,WHITE BLOOD CELL...DECLOZAPINEZENITH GOLDLINE...41.0 FLink    xml
  ▸00Q23518412DRUG LEVEL NOS ABOVE THERAPEUT...DECLOZAPINE11/15/99ZENITH GOLDLINE41.0 F 
3410819 ▸00Q13440092ASCITES,DYSPNOEA NOS,OEDEMA...DE,HOTHALOMID01/03/00CELGENE CORPORA...65.0 MLink    xml
  ▸00Q13446090DEMENTIA OF THE ALZHEIMER'S...DECLOZAPINEZENITH GOLDLINE...77.0 F 
  ▸00Q13476129DEMENTIA OF THE ALZHEIMER'S...DECLOZAPINEZENITH GOLDLINE...77.0 F 
3411464 ▸99Q43430202CHOLESTASIS,COMA NEC,DERMATITI...DE,RILEPONEX (CLOZA...11/16/99NOVARTIS PHARMA...55.0 MLink    xml
3412091 ▸99Q43431498CEREBRAL ARTERY THROMBOSIS,...DELEPONEX (CLOZA...11/19/99NOVARTIS PHARMA...46.0 MLink    xml
  ▸00Q13461704ARTERIOSCLEROSIS,CEREBRAL...DECLOZAPINE11/18/99NOVARTIS PHARMA...46.0 M 
3412204 ▸99Q43431496ACUTE CIRCULATORY FAILURE,...DE,RILEPONEX (CLOZA...08/16/99NOVARTIS PHARMA...31.0 FLink    xml
3413010 ▸99Q43431506WHITE BLOOD CELL COUNT INCREAS...DECLOZAPINEZENITH GOLDLINE...74.0 FLink    xml
3413017 ▸99Q43431510DEHYDRATION,WHITE BLOOD CELL...DECLOZAPINEZENITH GOLDLINE...78.0 MLink    xml
  ▸00Q13450679DEHYDRATION,LEUCOCYTOSIS NOSDECLOZAPINEZENITH GOLDLINE...78.0 M 
3413028 ▸99Q43431517AORTIC ANEURYSMDECLOZAPINEZENITH GOLDLINE...74.0 FLink    xml
  ▸00Q13478925AORTIC ANEURYSMDECLOZAPINEZENITH GOLDLINE...74.0 F 
3417604 ▸00Q13438018DEATHDECLOZAPINEZENITH GOLDLINE...81.0 MLink    xml
  ▸00Q13451137CHOKINGDECLOZAPINEZENITH GOLDLINE...81.0 M 
3417610 ▸00Q13438024WHITE BLOOD CELL COUNT INCREAS...DECLOZAPINEZENITH GOLDLINE...69.0 MLink    xml
  ▸00Q23484981PNEUMONIA NOSDECLOZAPINEZENITH GOLDLINE...69.0 M 
  ▸00Q23518413CARDIAC ARREST,DYSPHAGIA,...DECLOZAPINEZENITH GOLDLINE69.0 M 
3417618 ▸00Q13438030WHITE BLOOD CELL COUNT INCREAS...DECLOZAPINEZENITH GOLDLINE...66.0 FLink    xml
  ▸00Q23498767WHITE BLOOD CELL COUNT INCREAS...DECLOZAPINEZENITH GOLDLINE...66.0 F 
3421443 ▸00Q13443447CONDITION AGGRAVATED,GALL...DECLOZAPINEZENITH GOLDLINE...82.0 FLink    xml
3421445 ▸00Q13443449DEATHDECLOZAPINEZENITH GOLDLINE...68.0 MLink    xml
3426006 ▸00Q13445403ABDOMINAL DISTENSION,ABDOMINAL...DE,RICLOZAPINENOVARTIS PHARMA...48.0 MLink    xml
3426659 ▸00Q13446095CONDITION AGGRAVATED,MENTAL...DECLOZAPINEZENITH GOLDLINE...74.0 FLink    xml
  ▸00Q13458511CONDITION AGGRAVATED,MENTAL...DECLOZAPINEZENITH GOLDLINE...74.0 F 
  ▸00Q23518434CONDITION AGGRAVATED,MENTAL...DECLOZAPINEZENITH GOLDLINE74.0 F 
3427094 ▸00Q13446395CARDIOMYOPATHY NOS,DRUG LEVEL...DELEPONEX (CLOZA...07/14/99NOVARTIS PHARMA...33.0 MLink    xml
  ▸00Q23486064DRUG TOXICITY NOS,HEPATIC...DELEPONEX (CLOZA...07/14/99NOVARTIS PHARMA...37.0 M 
3429787 ▸00Q13449255ASPIRATION,CONSTIPATION,FAECAL...DECLOZAPINENOVARTIS PHARMA...47.0 MLink    xml
  ▸00Q13457859ACUTE CIRCULATORY FAILURE,...DECLOZAPINE07/16/96NOVARTIS PHARMA...49.0 M 

« Previous 1 2 ... 4 5 6 7 8 9 10 11 12 ... 111 112 Next »
2,483,089 adverse event cases, last updated on 01.20.2010 11:20 UTC